Psychiatry and Clinical Psychopharmacology

Vitamin D levels in children with autism spectrum disorders

Psychiatry and Clinical Psychopharmacology 2014; 24: Supplement S117-S118
Read: 546 Published: 18 February 2021

Objective: In this study, it is aimed to define serum levels of Vitamin D, calcium (Ca+2), phosphorus (P), alkaline phosphatase (ALP) and folate in young children with Autism Spectrum Disorders (ASD) and to compare them with those of normal controls and to explore the association between these serum values and the severity of the problem behavior, ASD symptom severity, and level of cognitive development.

Method: All participants were assessed by a child and adolescent psychiatry specialist according to DSM-IV-TR criteria and patients with the diagnosis of Autistic Disorder (AD) and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) were included in the study. None of the patients fulfilled the criteria for Asperger Syndrome (AS). All of the participants were interviewed and sociodemographic form and Aberrant Behavior Checklist (AbBC) were administered. Autism Behavior Checklist (ABC), Childhood Autism Rating Scale (CARS) and developmentally appropriate screening or IQ tests were administered to ASD patients. Besides, Vitamin D, Ca+2, P, ALP and folate levels of all participants were calculated at central and endocrinology laboratories of our university hospital from March 2013 to September 2013. Chi square tests, t tests and correlation analyses were used to evaluate the data.

Results: In 29.6% of the children with ASD and 38.9% of the normal children, Vitamin D deficiency was detected, however, the difference was not statistically significant between the groups. No statistically significant differences were detected between levels of Vitamin D, Ca+2, P, ALP and folate in children with ASD compared to those of controls. The correlational analysis in children with ASD revealed that AbBC, ABC, CARS scores were not correlated with biochemical and endocrine laboratory results.

Discussion: The results of the study showed that Vitamin D, Ca+2, P, ALP and folate levels in 3-8 years old children with ASD were not different from normal controls. The routine screening of Vitamin D levels in 3-8 years old children with ASD does not seem to feasible. In future studies, defining Vitamin D levels in cord blood or perinatal period and prospectively following up children may generate different results.

EISSN 2475-0581